Outlook Therapeutics, Inc. number of employees

Outlook Therapeutics, Inc. reported 17 employees at September 30, 2025 in its latest annual report. Revenue per employee was $83,149.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
September 30, 2025	17	—	$83,149	10-K, filed December 19, 2025

What the annual reports say

Employees and Human Capital Resources As of September 30, 2025, we had 17 full-time employees, seven of whom were primarily engaged in research and development activities and commercialization of ONS-5010/LYTENAVA and five of whom have a Ph.D. degree. 2025 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: ACRS vs OTLK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Outlook Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Outlook Therapeutics, Inc.